CDC: Smallpox responders wouldn't need revaccination in outbreak

Smallpox

Sep 25, 2003 (CIDRAP News) – Centers for Disease Control and Prevention (CDC) officials say healthcare workers who recently received smallpox shots would not need a second shot in the event of a smallpox outbreak in the next few years, despite a recent CDC advisory suggesting that they might.

A CDC guideline on smallpox vaccination and procedures, updated Aug 18, states that all smallpox team members should "maintain an up-to-date vaccination status. The appropriate interval for revaccination of [smallpox] response team members is currently under review and will be made available in the near future. In addition, upon confirmation of a smallpox outbreak, a repeat vaccination to boost the immune system response may be indicated for all team members to ensure their greatest protection."

But CDC spokesman Von Roebuck said people who were successfully vaccinated in the current program would not need another shot in the event of an outbreak. "In no way are we saying that if you were vaccinated already, you need to be vaccinated again," he told CIDRAP News.

The issue surfaced this week in San Diego. County health officials there took the CDC guideline to mean that they should revaccinate the local smallpox response team members if the disease re-emerged, according to a report in the San Diego Union-Tribune.

Roebuck said the intent of the guideline is to say that vaccinees eventually may need to be revaccinated. "That would be down the road, 5 to 7 to 10 years," when their immunity "perhaps could wear off," he said.

The duration of immunity resulting from a smallpox shot varies, but the consensus of smallpox authorities such as Dr. D. A. Henderson is that it usually begins to wane after 5 to 10 years.

Roebuck stressed that recent vaccinees who had a "take"—the characteristic lesion signaling an immune response—would be protected from smallpox if they had to respond to an outbreak anytime soon. "If they had a take, they're good to go," he said.

"We've said nothing in the sense that people who have been vaccinated in the past year of the program need to be revaccinated now," Roebuck said.

See also:

CDC document "Smallpox Vaccination Status and Procedures—Guidelines for Grantees using Licensed Undiluted Wyeth Dryvax Vaccine"
http://www.bt.cdc.gov/agent/smallpox/vaccination/statusprocedure.asp

This week's top reads

  1. FDA significantly limits COVID-19 vaccine recommendations

    Critics said today’s announcement is more evidence of the current administration’s willingness to undermine public trust in vaccines.

    Stephanie Soucheray
    FDA building

  2. Woman dies of Creutzfeldt-Jakob almost 50 years after taking prion-contaminated growth hormone

    The patient, who presented with gait imbalance and tremors, wasn't diagnosed until she was in a coma, shortly before she died.

    Mary Van Beusekom
    Woman in hospital bed

  3. Meta-analysis: Zika-infected pregnant moms 4 times more likely to have babies with microcephaly

    Five of 22 studies noted that over 50% of newborns had microcephaly, and the same number of studies observed that over 5% had congenital Zika syndrome. 

    Mary Van Beusekom

  4. HHS expected to discontinue COVID vaccine recommendations for some groups

    When CDC advisers widened their recommendation in 2023, most members were swayed by data, including those for long COVID, showing that no group is at low risk for the virus.

    Lisa Schnirring

  5. WHO advisers say current strains OK for COVID vaccine production

    Current vaccine strains show high neutralization against the latest variants, but the LP.8.1 antigen may provide similar or moderately higher cross-reactive antibody response.

    Lisa Schnirring
    senior vaccination

  6. US measles outbreak grows to 1,024 cases

    Texas remains the country's hot spot, with 718 cases. 

    Chris Dall
    Doctor treating child with measles

  7. Moderna pulls licensing submission for combo flu-COVID vaccine

    Moderna's combination vaccine was intended for adults 50 and older. 

    Stephanie Soucheray

  8. Flu vaccine efficacy 41% overall and 26% in older adults, per 2023-24 estimates

    Estimated effectiveness was 68% against influenza B and 32% against type A.

    Mary Van Beusekom
    Flu shot going into arm

  9. Mpox activity escalates in Sierra Leone

    Responding to the surge is a major focus, partly to prevent the spread to other West African countries. 

    Lisa Schnirring
    mpox virus

  10. Testing ties Listeria outbreak to ready-to-eat sandwiches

    An earlier investigation hinted at hospital food as a source, but evidence didn't reveal a specific item.

    Lisa Schnirring

Our underwriters